These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313 [TBL] [Abstract][Full Text] [Related]
6. Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus. Laheij RJ; Van Rossum LG; De Boer WA; Jansen JB Aliment Pharmacol Ther; 2002 May; 16(5):887-91. PubMed ID: 11966496 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus. Parrilla P; Ortiz A; Martinez de Haro LF; Aguayo JL; Ramirez P Gut; 1990 Sep; 31(9):964-7. PubMed ID: 2210462 [TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus. Koek GH; Sifrim D; Lerut T; Janssens J; Tack J Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496 [TBL] [Abstract][Full Text] [Related]
9. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Frazzoni M; Manno M; De Micheli E; Savarino V Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016 [TBL] [Abstract][Full Text] [Related]
12. Survival after antireflux surgery versus medication in patients with reflux oesophagitis or Barrett's oesophagus: multinational cohort study. Yanes M; Santoni G; Maret-Ouda J; Ness-Jensen E; Färkkilä M; Lynge E; Pukkala E; Romundstad P; Tryggvadóttir L; -Chelpin MVE; Lagergren J Br J Surg; 2021 Jul; 108(7):864-870. PubMed ID: 33724340 [TBL] [Abstract][Full Text] [Related]
13. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study. Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591 [TBL] [Abstract][Full Text] [Related]
14. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications. Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA; Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305 [TBL] [Abstract][Full Text] [Related]
15. The changing spectrum of gastroesophageal reflux disease. Todd JA; Johnston DA; Dillon JF Eur J Cancer Prev; 2002 Jun; 11(3):215-9. PubMed ID: 12131654 [TBL] [Abstract][Full Text] [Related]
16. Barrett's oesophagus: a clinical study of 52 patients. Cooper BT; Barbezat GO Q J Med; 1987 Feb; 62(238):97-108. PubMed ID: 3498962 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Veldhuyzen van Zanten SJ; Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Escobedo S; Sinclair P Aliment Pharmacol Ther; 2006 Mar; 23(5):595-9. PubMed ID: 16480398 [TBL] [Abstract][Full Text] [Related]